Codexis (CDXS) Total Current Liabilities (2010 - 2026)
Codexis (CDXS) recorded quarterly Total Current Liabilities of $14.8 million in Q1 2026, down 41.34% quarter-over-quarter from $25.3 million in Q4 2025, and down 28.95% on a YoY basis from $20.9 million in Q1 2025.
Codexis (CDXS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Codexis' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $14.8 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 28.95% year-over-year to $14.8 million; the TTM figure through Mar 2026 stood at $14.8 million (down 28.95% YoY), while the FY2025 annual figure was $25.3 million, up 7.06% from the prior year.
- Total Current Liabilities was $14.8 million for Q1 2026 at Codexis, down from $25.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $49.1 million in Q4 2022 to a low of $14.8 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $29.5 million across 5 years, with a median of $30.0 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Total Current Liabilities soared 47.03% in 2022, then slumped 50.11% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $49.1 million in 2022, then fell by 26.98% to $35.8 million in 2023, then slumped by 34.0% to $23.6 million in 2024, then rose by 7.06% to $25.3 million in 2025, then plunged by 41.34% to $14.8 million in 2026.
- The last three Total Current Liabilities figures came in at $14.8 million (Q1 2026), $25.3 million (Q4 2025), and $18.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 72.86 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 14.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.85 Mn |
| Dec 31, 2025 | 25.32 Mn |
| Sep 30, 2025 | 18.48 Mn |
| Jun 30, 2025 | 15.24 Mn |
| Mar 31, 2025 | 20.90 Mn |
| Dec 31, 2024 | 23.65 Mn |
| Sep 30, 2024 | 35.13 Mn |
| Jun 30, 2024 | 30.54 Mn |
| Mar 31, 2024 | 29.08 Mn |
| Dec 31, 2023 | 35.83 Mn |
| Sep 30, 2023 | 38.42 Mn |
| Jun 30, 2023 | 35.74 Mn |
| Mar 31, 2023 | 38.31 Mn |
| Dec 31, 2022 | 49.07 Mn |
| Sep 30, 2022 | 31.91 Mn |
| Jun 30, 2022 | 30.01 Mn |
| Mar 31, 2022 | 29.50 Mn |
| Dec 31, 2021 | 33.37 Mn |
| Sep 30, 2021 | 33.48 Mn |
| Jun 30, 2021 | 24.09 Mn |